...to get through the next two years in good shape. And they would include for example the tobacco sector, pharmaceuticals (GlaxoSmithKline and AstraZeneca), telecoms to some extent and the oil sector, despite the fall in the oil price. "I am still very optimistic...

...3, ABN AMRO, AOL, BAE Systems, BBC, Bloomberg, Boeing, Citigroup, Coca Cola, Daimler Chrysler, Deutsche Bank, Ericsson, Ford, GlaxoSmithKline, Lloyd TSB, NASA, Nestle, the New York Stock Exchange, Reuters, Shell, T-Mobile, the U.S. Department of Energy, the...

...and healthcare stocks were also advancing, with chipmaker Infineon Technologies (IFX: , , ) (DE:623100: , , ) up 4.3% and drugmaker GlaxoSmithKline (UK:GSK: , , ) up 4.7%. The U.K. FTSE 100 index rose 4.2% to 4,431.82, the German DAX 30 index climbed 2.9%...

...the rise of the bacteria, which was gaining momentum in some countries before the vaccine’s adoption. For example, researchers from GlaxoSmithKline, which is introducing its own pneumococcal vaccine, reported last month that Serotype 19A became more common...

...and regulatory compliance. Within four years of operation, A-Bio has established a strong track record with customers such as GlaxoSmithKline Biologicals, Novo Nordisk, Artisan Pharma and others. For more on A-Bio: www.a-bio.com. About Bio*One Capital ...

...defensives that did not run up in 2007 have held up in the recent correction? Hindustan Unilever, Colgate Palmolive, Nestle India, GlaxoSmithKline Pharma and Lupin have actually managed positive returns or remained flat in 2008 and have been among the top...

...trials for a respiratory inflammation drug. The drug is part of the research and development collaboration between Ranbaxy and GlaxoSmithKline. As per the agreement, Ranbaxy will be involved in conducting phase I and phase II clinical studies, while GlaxoSmithKline...

...comes after an audit by the Medical Products Agency, Sweden, in June. Kemwell’s customers include AstraZeneca, Bayer, GlaxoSmithKline, Johnson & Johnson, Novartis and Pfizer. “We now want to extend our services to similar customers for their global needs,”...

...is low, especially in managerial positions. More clinical research is being channelled into India from big pharma like Pfizer, GlaxoSmithKline, Novartis and Bristol Myers Squibb, but the entire clinical machinery needs to be cranked up further if performance...

...Oct. 13 (UPI) -- Researchers at McGill University in Montreal, King's College London and the British drug firm GlaxoSmithKline Inc. say 1 in 7 men have genetic risk of balding. The researchers identified two genetic variants in Caucasians that together produce...